A patient with ankylosing spondylitis who developed infliximab-induced lupus and treated with etanercept

Saved in:
Bibliographic Details
Published inRheumatology international Vol. 34; no. 3; pp. 443 - 444
Main Authors Akgül, Özgür, Kılıç, Gamze, Kılıç, Erkan, Cüce, İsa, Özgöçmen, Salih
Format Journal Article
LanguageEnglish
Published Berlin/Heidelberg Springer Berlin Heidelberg 01.03.2014
Springer Nature B.V
Subjects
Adult
Antibodies, Monoclonal - adverse effects
Antibodies, Monoclonal - therapeutic use
Antirheumatic Agents - adverse effects
Antirheumatic Agents - therapeutic use
Dose-Response Relationship, Drug
Etanercept
Female
Humans
Immunoglobulin G - therapeutic use
Infliximab
Letter to the Editors
Lupus Erythematosus, Systemic - chemically induced
Lupus Erythematosus, Systemic - diagnosis
Medicine
Medicine & Public Health
Receptors, Tumor Necrosis Factor - therapeutic use
Rheumatology
Spondylitis, Ankylosing - drug therapy
Treatment Outcome
Tumor Necrosis Factor-alpha - antagonists & inhibitors
Withholding Treatment
Inflammatory Bowel Disease
Rheumatoid Arthritis
Infliximab
Etanercept
Ankylose Spondylitis
Online AccessGet full text

Cover

More Information
ISSN:0172-8172
1437-160X
DOI:10.1007/s00296-012-2617-8